Profusa announced it received ISO 13485:2016 certification for its Lumee Oxygen Platform from an EU MDR notified body. This is a crucial step towards obtaining CE marking and commercializing its medical device in the European Union, indicating progress in its regulatory pathway.
Profusa announced it has secured its ISO 13485:2016 certificate from GMED, an EU MDR notified body, for its Lumee Oxygen Platform. This certification is a foundational step for medical device companies, demonstrating a compliant quality management system, and is essential for pursuing CE marking under the stringent EU Medical Device Regulation (MDR). For Profusa, this significantly de-risks its path to commercialization in the European Union, as ISO 13485 is a prerequisite for MDR conformity assessment and often for hospital procurement. This is a positive long-term development for the company, as it opens up a major market, though the immediate short-term stock impact might be moderate as it's a step in a longer regulatory process rather than final market approval. The key opportunity for traders is the increased likelihood of future revenue streams from the EU market.